Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy

Mingyu Zhu(Tianjin Medical University Cancer Institute and Hospital), Zhansheng Jiang(Tianjin Medical University Cancer Institute and Hospital), Haiyan Cui(Tongji University), Qiang Zhao(First Affiliated Hospital of Zhengzhou University), Lu Zhang(Henan University), Baochao Zhai(Tianjin Medical University Cancer Institute and Hospital), Hao Wang(Tongji University), Richeng Jiang(Tianjin Medical University Cancer Institute and Hospital)
Frontiers in Immunology
January 6, 2022
Cited by 27


Related Papers